Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly sales of $38.000 million which missed the analyst consensus estimate of $46.044 million by 17.47 percent. This is a 52.91 percent decrease over sales of $80.702 million the same period last year.
Ginkgo Bioworks Holdings Q1 Sales $38.000M Miss $46.044M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.